MML applies high-throughput quantum chemical modelling, Artificial Intelligence (AI) heuristics and state-of-the-art electron microscopy to the study and development of immune interventions and drug design. Quantum Immunology, MML’s flagship initiative, applies hybrid molecular modelling and heuristics to receptor-antigen interactions, aiming to create interventions relevant to infectious diseases, immune disorders, neurological conditions and aging. MML also combines theoretical modelling and Transmission Electron Microscopy (TEM) to optimize drug design through detection of new polymorphic crystal structures, stability prediction of pharmaceutical Amorphous Solid Dispersions (ASD) and computational analysis of poorly-soluble drugs.
Applications